We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$7.72B
AUM Growth
+$487M
(+6.7%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
1,037
New
61
Increased
505
Reduced
426
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$28.2M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$18.5M |
| 3 |
Deere & Co
DE
|
+$15.6M |
| 4 |
TSMC
TSM
|
+$13.2M |
| 5 |
Citigroup
C
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$36.5M |
| 2 |
HTZ
Hertz Global Holdings, Inc.
HTZ
|
+$15.6M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$11.8M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.66M |
| 5 |
Dycom Industries
DY
|
+$9.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.63% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCO
276
DELISTED
Taubman Centers Inc.
TCO
| $6.89M | 0.09% |
92,655
+6,378
| +7% | +$493K |
|
277
BWX Technologies
BWXT
$16B
| $6.88M | 0.09% |
179,186
-8,160
| -4% | -$308K |
|
278
Eli Lilly
LLY
$1.07T
| $6.87M | 0.09% |
85,647
-1,145
| -1% | -$91.6K |
|
279
Amphenol
APH
$188B
| $6.86M | 0.09% |
422,460
-362,472
| -46% | -$5.51M |
|
280
Ameriprise Financial
AMP
$46.8B
| $6.83M | 0.09% |
68,498
+2,768
| +4% | +$268K |
|
|
FISV
281
Fiserv Inc
FISV
$27.2B
| $6.82M | 0.09% |
137,022
+20,636
| +18% | +$1.08M |
|
282
F5
FFIV
$22.1B
| $6.75M | 0.09% |
54,112
-898
| -2% | -$109K |
|
283
Rio Tinto
RIO
$148B
| $6.74M | 0.09% |
201,723
+15,436
| +8% | +$492K |
|
284
Capital One
COF
$124B
| $6.69M | 0.09% |
93,136
-10,575
| -10% | -$726K |
|
285
Cardinal Health
CAH
$53.4B
| $6.68M | 0.09% |
86,005
-1,931
| -2% | -$156K |
|
286
Crown Castle
CCI
$32.7B
| $6.67M | 0.09% |
70,821
+9,358
| +15% | +$900K |
|
287
Colgate-Palmolive
CL
$72.6B
| $6.67M | 0.09% |
89,956
+782
| +0.9% | +$57.8K |
|
288
Franklin Electric
FELE
$4.67B
| $6.67M | 0.09% |
163,803
-2,683
| -2% | -$102K |
|
289
Devon Energy
DVN
$51.9B
| $6.67M | 0.09% |
151,142
+2,364
| +2% | +$96K |
|
290
Fortive
FTV
$19B
| $6.66M | 0.09% |
+207,459
| New | +$6.66M |
|
291
Rithm Capital
RITM
$5.09B
| $6.66M | 0.09% |
482,008
-6,475
| -1% | -$90.3K |
|
|
QVCGA
292
DELISTED
QVC Group Inc Series A
QVCGA
| $6.66M | 0.09% |
6,851
-302
| -4% | -$333K |
|
|
DFT
293
DELISTED
DuPont Fabros Technology Inc.
DFT
| $6.61M | 0.09% |
160,220
+17,451
| +12% | +$787K |
|
294
FS KKR Capital
FSK
$2.98B
| $6.58M | 0.09% |
173,586
+9,663
| +6% | +$366K |
|
295
Federal Realty Investment Trust
FRT
$10.9B
| $6.54M | 0.08% |
42,508
-602
| -1% | -$97.3K |
|
296
Nucor
NUE
$56.4B
| $6.5M | 0.08% |
131,456
+9,015
| +7% | +$459K |
|
|
GPT
297
DELISTED
Gramercy Property Trust
GPT
| $6.47M | 0.08% |
223,846
+7,172
| +3% | +$208K |
|
298
American Water Works
AWK
$26.3B
| $6.47M | 0.08% |
86,436
-16,062
| -16% | -$1.26M |
|
299
Crown Holdings
CCK
$12.8B
| $6.43M | 0.08% |
112,709
-3,583
| -3% | -$192K |
|
300
Clorox
CLX
$11.6B
| $6.43M | 0.08% |
51,347
+925
| +2% | +$121K |
|
Similar funds
Natixis Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Natixis Advisors held 1,037 positions worth $7.72B, up 6.7% from $7.23B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Natixis Advisors's Q3 2016 filing shows 61 new, 505 increased, 426 reduced and 45 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 70,417 shares worth $28.3M. The largest sale was ARM HOLDINGS PLC ADS, an estimated $36.5M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Natixis Advisors's largest Q3 2016 buy was Regeneron Pharmaceuticals: 70,417 shares worth $28.3M.
- Natixis Advisors added most to TSMC in Q3 2016, an estimated $13.2M increase.
- Natixis Advisors's biggest Q3 2016 reduction was Hertz Global Holdings, Inc., cutting an estimated $15.6M.
- Natixis Advisors fully exited ARM HOLDINGS PLC ADS in Q3 2016, selling an estimated $36.5M.
- Natixis Advisors's ten largest holdings make up 13% of its $7.72B portfolio in Q3 2016.
- Natixis Advisors opened 61 new positions and closed 45 in Q3 2016.
- Natixis Advisors's portfolio value rose 6.7% quarter-over-quarter to $7.72B.
Based on Natixis Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.